In recent years, the therapeutic potential of psychedelics has garnered significant attention, driven by growing scientific research. Psychedelic substances such as psilocybin and LSD have evolved far beyond their associations with countercultural movements of the past. Today, they are at the forefront of clinical Psychiatry, offering new and promising approaches to the treatment of mental health conditions like depression, PTSD and substance use disorders. Additionally, other compounds, such as ketamine, are steadily gaining recognition in psychiatric practice and there are several countries already incorporating these substances into established therapeutic frameworks. This shift signifies a broader acceptance of psychedelics within the medical community and society at large.
This MasterClass will delve into the most up-to-date research in the field of psychedelics, focusing on groundbreaking studies from leading institutions like Imperial College London. Participants will explore the profound neurobiological effects of psychedelics through advanced neuroimaging techniques that reveal how these substances interact with brain networks to produce their effects. By examining the latest findings, attendees will gain a deeper understanding of the mechanisms through which psychedelics can alleviate psychological distress and promote well-being. Moreover, critical discussions will be held on the ethical considerations surrounding the clinical use of these substances, ensuring that practitioners are well-informed about the potential risks and benefits involved.
As the body of evidence supporting the efficacy of psychedelic treatments continues to develop, it becomes increasingly important to foster informed dialogue about their potential role in mental health care. The stigma that has long surrounded these substances is gradually dissipating, allowing for a more nuanced conversation about their therapeutic applications. This MasterClass aims to create a space for professionals to engage with this evolving topic, encouraging collaboration and innovative thinking.
Tailored for psychiatrists, psychologists, healthcare professionals, as well as pre- and post-graduate students, this event will also feature a practical workshop on the clinical application of ketamine. This rapidly-acting psychedelic compound is gaining momentum in therapeutic contexts. Participants will have the opportunity to deepen their knowledge about this innovative practice, allowing them to better understand the implications and benefits of psychedelic therapies. Join us for a thorough exploration of the science, ethics, and evolving clinical applications of psychedelic therapy, as we address one of the most pressing topics in modern mental health treatment.

Target Group:
- Psychiatrists
- Psychologists
- Healthcare professionals
- Pre- and post-graduate students in Medicine and Psychology

This masterclass does not provide credentials for the exercise of medicine for those without appropriate training, recognition and registered at the "Ordem dos Médicos" or international equivalent institutions.